GLP1R and rheumatoid arthritis: In the RA-diabetes subgroup, weighted IRs for MACE in new users of GLP-1-RAs and DPP-4is were 16.2 and 40.4 per 1,000 person-years, respectively, corresponding to a HR of 0.39 (0.22–0.69) and a RD of -24.2 (-43.7 to -4.7).